GLP-1 drugs were originally used to treat diabetes, but are now a popular method of weight loss, even as the drugs face concerns over affordability, insurance coverage and potential side effects, as Newsday has previously reported
Most insurance plans, including BCBS, provide a drug list of its covered drugs in several tiers
Low blood sugar is a key cause of dizziness, especially in people with diabetes who also use insulin or sulfonylureas, since glucose is the brains primary energy source
Dip Powders are more durable than gel polish and just as durable as acrylics
Varios factores explican esta trayectoria de crecimiento: Factores impulsores del crecimiento: Eficacia clnica demostrada en estudios SURPASS para diabetes (reduccin de A1C hasta 2.5% y prdida de peso moderada) y SURMOUNT para obesidad (prdida de peso de 15-22% en estudios clnicos) Cobertura por aseguradoras privadas para diabetes tipo 2 (Mounjaro) Aumento en la conciencia pblica sobre agonistas GLP-1 Prescripcin off-label para prdida de peso antes de la aprobacin de Zepbound Sin embargo, el crecimiento ha enfrentado limitaciones por escasez de suministro intermitente, documentada en la lista de escasez de medicamentos de la FDA, particularmente en dosis iniciales (2.5 mg y 5 mg), lo que ha afectado el inicio de nuevos pacientes en ciertos perodos durante 2023 y principios de 2024
